These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 28296770

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effects of an Intrathecal Drug Delivery System Connected to a Subcutaneous Port on Pain, Mood and Quality of Life in End Stage Cancer Patients: An Observational Study.
    Giglio M, Preziosa A, Mele R, Brienza N, Grasso S, Puntillo F.
    Cancer Control; 2022; 29():10732748221133752. PubMed ID: 36281899
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and Safety of Ropivacaine Addition to Intrathecal Morphine for Pain Management in Intractable Cancer.
    Huang Y, Li X, Zhu T, Lin J, Tao G.
    Mediators Inflamm; 2015; 2015():439014. PubMed ID: 26556955
    [Abstract] [Full Text] [Related]

  • 25. Intrathecal combination of ziconotide and morphine for refractory cancer pain: a rapidly acting and effective choice.
    Alicino I, Giglio M, Manca F, Bruno F, Puntillo F.
    Pain; 2012 Jan; 153(1):245-249. PubMed ID: 22082570
    [Abstract] [Full Text] [Related]

  • 26. Retrospective Analysis of Intrathecal Drug Delivery: Outcomes, Efficacy, and Risk for Cancer-Related Pain at a High Volume Academic Medical Center.
    Sayed D, Monroe F, Orr WN, Phadnis M, Khan TW, Braun E, Manion S, Nicol A.
    Neuromodulation; 2018 Oct; 21(7):660-663. PubMed ID: 29446171
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Initiation of Intrathecal Drug Delivery Dramatically Reduces Systemic Opioid Use in Patients With Advanced Cancer.
    Sindt JE, Odell DW, Dalley AP, Brogan SE.
    Neuromodulation; 2020 Oct; 23(7):978-983. PubMed ID: 32459393
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Oral naltrexone to enhance analgesia in patients receiving continuous intrathecal morphine for chronic pain: a randomized, double-blind, prospective pilot study.
    Hamann S, Sloan P.
    J Opioid Manag; 2007 Oct; 3(3):137-44. PubMed ID: 18027539
    [Abstract] [Full Text] [Related]

  • 34. Intrathecal Drug Delivery Systems for Cancer Pain: A Health Technology Assessment.
    Ontario Health .
    Ont Health Technol Assess Ser; 2024 Oct; 24(2):1-162. PubMed ID: 38344326
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Intrathecal opioids for intractable pain syndromes.
    Koulousakis A, Kuchta J, Bayarassou A, Sturm V.
    Acta Neurochir Suppl; 2007 Oct; 97(Pt 1):43-8. PubMed ID: 17691355
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.